The Center for Addiction & Disease Risk Exacerbation (CADRE) is a NIH Center of Biomedical Research Excellence (COBRE) led by Peter Monti, Jasjit S. Ahluwalia, Jennifer Tidey & Tyler Wray. The center supports innovative, interdisciplinary research aimed at identifying how SU exacerbates disease through novel approaches, with a particular emphasis on high-risk and underserved populations. CADRE is housed in the Center for Alcohol & Addiction Studies at the Brown University School of Public Health.
Center for Addiction & Disease Risk Exacerbation
CADRE
The COBRE Center for Addiction and Disease Risk Exacerbation (CADRE) focuses on understanding the mechanisms through which substance use (SU) increases the risk for and progression of chronic disease.
CADRE
The COBRE Center for Addiction and Disease Risk Exacerbation (CADRE) focuses on understanding the mechanisms through which substance use (SU) increases the risk for and progression of chronic disease.
Learn more about CADRE
Established in 2019, the Center for Addiction and Disease Risk Exacerbation (CADRE), is a federally funded NIH Center of Biomedical Research Excellence (COBRE).
Meet the dedicated staff at the Center for Addiction & Disease Risk Exacerbation.
Learn more about the CADRE Administrative Core, Clinical Laboratory Core and REACH Core.
Partner with Us
We offer clinical and recruitment services through our Clinical Laboratory Core and REACH Core. Read more about what we can offer you.
The Clinical Laboratory Core (CLC) provides investigators with the tools they need.
The REACH Core is a team of recruitment and marketing experts. We offer a paid service to efficiently manage your enrollment goals to ensure they are met on time.
"We're only at the tip of the iceberg with regard to understanding the role of substance use on chronic disease... The early career scientists who will be supported by this funding will be the people who ultimately chip away at that iceberg."
Center Director
Recent news from CADRE
News & Events
Alcohol Clin Exp Res (Hoboken)
Study Reveals How Alcohol Dose and Drinking History Shape Immune Response
Randomized trial finds distinct immune biomarker changes in light vs. heavy drinkers, highlighting dose- and behavior-dependent effects of alcohol on inflammation.
Read Article
News from CADRE
CADRE Team Presents Research at 2025 RI IDeA Symposium
Abby Morales, Kevin McCurdy, and Jacob Talamantes represented CADRE at this year’s Emerging Areas of Science IDeA Symposium in Providence, RI, presenting cutting-edge research on alcohol use disorder and related health outcomes.
Read Article
News from Brown
New opioid testing techniques could lead to better therapies
Former CADRE Investigator, Carolina Haass-Koffler, collaborates with Brown University engineers to pioneer groundbreaking diagnostic tools that detect opioid exposure in adults and newborns.
Read Article